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IV-1 disease produces a primary neurologic/neuropsychiatric disorder, although the precise contribution of virus to either brain or spinal cord pathology or to clinical symptoms is thought not to be due to actual infection of neurons or oligodendrocytes (1) . Infection in fetal brain is difficult to detect even by PCk or in situ hybridization, and virus isolation from these brains is rare. When infection occurs in fetal brain, it does so in few cells and may be latent or defective (2) . HIV-1 nucleic acids and proteins are more easily detected in pediatric than in fetal brain; nevertheless, infection in neonatal brain is at a lower level than in adult brain, and productive infection is not usually evident (3) .
Because pathology occurs in cells not infected with vires, it is possible that cytokines and small toxic molecules are indirectly at work in central nervous system (CNS) 1 AIDS (4). In AIDS patients, HIV-1 infection increases the levels of several proinflammatory cytokines, such as IL-1, IL-6, and TNF-IX in vivo and in vitro (for review see reference 4). TNF-o~ and IL-1 have been found to be elevated in CNS AIDS brain tissue, with significantly higher amounts in demented HIV-l-infected patients (5) . Levels of TNF-o~ have been correlated with spinal cord vacuolar 1Abbreviations used in this paper: ANOVA, analysis of variance; AZT, azidothymidine; CNS, central nervous system; CYTO, cytokines; GCT, giant cell tumor supernatant; iNOS, inducible nitric oxide synthase; Dil-0t-LDL, acetylated low-density lipoprotein; mP, NA, messenger RNA; NO, nitric oxide; NO~-, total nitric oxide; P, CA-1, Ricinus communis agglutinin 1; WP,., wild type. myelopathy and brain encephalitis (5) . The findings of HIV-1 induction of IL-1, TNF-o~, and IL-6 in macrophages and glia are interesting since all three of these cytokines up-regulate HIV-1 replication in T cells or MO (1, 6) .
The primary cell type infected in vivo in CNS AIDS is the microglial cell (1) . The CD4-independent infections in human astrocytes (malignant or primary fetal) were usually transient, nonproductive/latent, or partially defective and did not lead to in vitro cytopathicity (7) (8) (9) . In human adult brain, CD4* macrophages were shown to fuse and die after in vitro infection by a macrophage-tropic strain of HIV-1 (10), but there is some controversy remaining as to whether human microglia are CD4 + and whether they can be infected (11, 12) .
Recently, human macrophages, astrocytes, and astrocytomas have been shown to produce nitric oxide (NO) via inducible NO synthase (iNOS) in response to cytokines and gp120 (13) (14) (15) (16) . iNOS has been seen in AIDS retina, suggesting NO as a possible mechanism for CNS damage (17) ; NO damages neurons and oligodendrocytes in vitro. Because gp120 and gp41 are able to induce IL-1 and TNF-ot in glial cultures (18, 19) , we have mapped epitopes in HIV-1 envelope that induce IL-1, TNF-cx, and iNOS at the protein and messenger 1KNA (mlKNA) level. In the absence of significant productive infection, gp120 carboxy terminus and gp41 amino terminus epitopes give rise to cytokines and NO production in human glial cultures from tissue taken at different stages of development.
Materials and Methods

Primary Human Glial Cells: Establishment of Cultures and Glial
Cell Type Identification. The human glial cultures were established from adult, neonatal, and fetal brain tissue. The adult and neonatal brain tissue was obtained from epilepsy patients undergoing surgical resections for intractable seizures. Tissues from four adults were obtained; the patients' average age was 23.8 -+ 4.0 yr (range 18.0-32.0 yr). The tissue was derived from frontal and temporal lobe regions. The neonatal brain tissues were procured from 10 cases, with an average age of 3.1 + 2.0 yr (range 1.4-5.0 yr). These tissues were mainly from temporal lobectomies. Entire brains of 10 aborted fetuses were obtained from Advanced Bioscience Resources, Inc. (Alameda, CA). They were from fetuses 19.8 + 1.8 wk old (range 17.5-24.0 wk). Human brain tissue was prepared as previously described (18) and cultured in Iscove's modified Dulbecco's medium (Irvine Scientific, Santa Aria, CA) containing 10% non-heat-inactivated FCS (Gemini Bioproducts, Inc., Calabasas, CA) as well as L-glutamine (2 mM) and gentamicin sulfate (50 !~g/ml), both purchased from lrvine Scientific. Once cultures were established (1-4 wk), they were split at passage 1 and maintained in two variations of Iscove's medium (see above) containing glial growth factors. One medium contained 10% giant cell tumor supernatant (GCT; AIDS Research and Reference Reagent Program, Rockvitle, MD); this was used to duplicate culture conditions previously described for infection of human adult microglia (10) . A second medium (cytokines [CYTO]) contained known concentrations of microglial growth factors: M-CSF, GM-CSF, and IL-3 (each used at 2.8 ng/ml, Immunex Corp., Seattle, WA).
For phenotyping, viable or fixed glial cells were stained as previously described (18) . Astrocytes were detected using a polyclonal antiglial fibrillary acidic protein antibody (1:100; Boehringer Mannheim Corp., Indianapolis, IN). Microglia were labeled using monoclonat EBM-11 (anti-CD68, I:50; DAKO Corp., Carpinteria, CA), fluorescein-conjugated Ridnus communis aggludnin 1 (RCA-I), 1:50 (Vector Laboratories, Inc., Burlingame, CA), and, for receptors for acetylated low-density lipoprotein, 1 tzg/ml 1,1 '-dioctadecyl-l-3,3,3'3'-tetramethyl indocarbocyanine perchlorate-conjugated LDL (DiI-~-LDL) (Biomedical Technologies, Inc,, Stoughton, MA). A proportion ofastrocytes also stains with RCA-1. Polyclonal Factor VIII antibody (1:50; DAKO Corp.) was used to detect endothelial cells. Staining for neurons was with anti-neuronspecific enolase (1:50; DAKO Corp.), and for oligodendrocytes with polyclonal antibody to galactocerebroside (1:20, Boehringer Mannheim Corp.). The major histocompatibility complex class II antigens were detected on astrocytes and microglia with an anti-HLA-DR antibody (1:50, Becton Dickinson & Co., Mountain View, CA). The presence of CD4 antigen on astrocytes and nilcroglia was also assessed (1:100, OKT4A; Ortho Diagnostic Systems, Inc., Raritan, NJ). For pathological assessment, cells were stained with a buffered differential Wright's stain (Camco Quik Stain; Baxter Scientific Products, McGaw Park, IL).
Preparation and Quantitation of Reconlbinant env Proteins from env:vaccinia Virus Infections. Recombinant viruses were provided to us by Drs. Bernard Moss and Patricia Earl (National Institutes of Health, Bethesda, MD). These included six serial truncation mutants from the carboxy terminus of the full-length gp160 engineered into vaccinia virus and expressed in HeLa cells as previously described (19) . Controls included medium alone and wildtype (WR) vaccinia virus-infected and mock-infected (medium alone) HeLa cells, vPE or WR virus titers were determined, stocks were prepared, and vPE proteins were quantitated on Western blots (19) . When titered on CV-1 or HeLa cells, no infectious vaccinia virus was detected in these vPE or WR supernatants.
Treatment of Glial Cuhures with env Proteins from Recombinant Vaccinia Viruses. Glial cells at 10('/nil in 24-well plates (Falcon Labware, Becton Dickinson & Co.) were preconditioned overnight with the serumless UltraCHO medium (BioWhittaker, Inc., Walkersville, MD) followed by exposure to medium alone or medium containing equivalent moles of recombinant vPE env proteins, WIK, or mock-infected control supernatants. To control for any effects of vaccinia virus proteins, WR control supernatants were added to glial cells for the same length of time and at a concentration equal to the highest concentration of any of the vPE supernatants. After replacement of medium and an additional 2-h incubation, the glial cell supernatants were harvested. Theretbre, the time designated for glial cell supematant harvests for IL-I and TNF-c~ is a total time of 4 h after initial exposure to env proteins or control supernatants. While other time points (8 h, 24 h) were examined, 4 h proved to be optimal. These gliat cell supernatants contained no HIV-1 or vaccinia virus proteins as determined by analysis of Western blots using anti-gp160 or anti-gp41 and antivaccinia virus. This is probably due to the fact that the glial cells were washed after their 2 h exposure to supernatants from Heka cells. For NO measurements, the incubation of glial cells with env proteins proceeded for 1 wk before the supernatants were harvested, which proved to be a peak production time point.
Treatment of Glial Cultures with Bacterially Produced Recombinant env Proteins and Heat-inactivated HIV-I Virus. R.ecombinant HIV-1 env proteins (gp160, gp120, and gp41) and the control gag protein (p24) produced in bacteria were purchased from American BioTechnologies (Cambridge, MA) and used to stimu-late glial cell cultures at 2 ~glml. As described previously (18) , HIV-1NL4_ 3 and HIVrqFN_SX were gradient purified, heat inactivated at 65~ for 45 rain, and added to glial cells at a p24 concentration of 100 ng/ml. For total NO (NOx-) production and IL-1/ TNF-ot/iNOS Northern blot analyses, stimulation with IL-113 (5 ng/ml) plus IFN-',/ (70 ng/ml) (both cytokines from Immunex Corp.) was used as a positive control. With recombinant env proteins and heat-inactivated HIV-1 strains, stimulation of glial cells was performed for 4 h and 1 wk for assessment of IL-1/TNF-ci and NO, respectively. As a control for the bacterially expressed recombinant envelope proteins, the gag protein of HIV-1, p24, was used as a negative control for the production of NO.
HIV-1 Infection of Glial Cells. Gradient-purified virus (18) (19) (20) from the T cell-tropic strain of HIV-1 (NL4-3) and the MOtropic strains JR-FL and JR-CSF as well as a hybrid recombinant strain (NFN-SX) (18, 21) were used to attempt to infect human glial cultures. Glial cultures and control PBLs at 106 cells/culture in media with GCT or cytokines were exposed to 104-105 infectious U (300-500 ng/culture, p24 titer as measured by the HIV-1-specific ELISA [Abbott Laboratories, North Chicago, IL]). At this multiplicity of infection, as expected, maximal infection of the PBLs with the virus occurred at 1 viral DNA copy per 1,000 cells. After exposure to virus, 10% of the total cells was assayed by PCR. As fewer brain cells were exposed to virus, the relative amount of virus added per cell was ~50-fold higher for the brain-derived cells. In one experiment, tissue was processed into a glial cell suspension but was not cultured; rather, this fresh cell suspension was placed in Iscove's medium (with no additive or with GCT or CYTO) and exposed to virus immediately.
Endotoxin levels of all reagents were measured by the limulus amebocyte lysate assay kit (BioWhittaker, Inc., Walkersville, MD). Only those recombinant proteins, azidothymidine (AZT) or heat-inactivated viruses, live viruses, vPE, WR, and HeLa supernatants that had an endotoxin content of ~<10 pg/ml were used to treat the glial cells (19) .
PCR Analysis of HIV-I Entry and Infection in Glial Cells.
At the times designated above, DNA was recovered and subjected to 25 cycles of PCR amplification according to techniques previously described (18, 20) . Quantitation was accomplished by analyzing in parallel a standard curve of cloned HIV-1jR_cs F DNA linearized with EcoRl, which does not cleave viral sequences. Entry of virus into cells was determined by choosing primer pairs for PCR that detect initiation (primer pairs M667/AA55) and completion (primer pairs M667/M661) of reverse transcription.
[~-globin DNA amplification was used as an internal control for the amount of DNA being amplified in glial cells (20).
IL-1, TNF-ee, and NOx-Assays. As previously described by this laboratory, IL-1 activity was measured using the LBRM 331A5 conversion assay, and TNF-o~ was measured by cytotoxicity ofL929 cells (18) . NO production was measured at day 3 and day 7 as described earlier. The nitrite (NO2-) plus nitrate (NO3-) determination yields total NO levels and was performed using boiling vanadium (III) with detection by means of chemiluminescence (22, 23) .
Northern Blot Analysis of Cytokine and iNOS mRNA. The presence, regulation, or induction ofmRNA for IL-1 and TNF-o~ in glial ceils after env protein exposure was monitored by Northern blot analysis. Glial cells were incubated with env proteins from supernatants of vaccinia virus recombinants. As a positive control, cells were stimulated with IL-113 (5 ng/ml) plus IFN-y (70 ng/ml) (both gifts from Immunex Corp.); the negative controls were WR infected, HeLa cell supernatant, or medium alone. The cell pellets were harvested after a 1-h and a 3-h exposure for cytokine mRNA and a 6-h exposure for iNOS mRNA. Total RNA was isolated using previously published techniques (19) .
Human IL-113 mRNA was probed using a 1.05-kb PstI cDNA fragment contained in pBR322 vector. Human TNF-cl mRNA was detected by hybridization with a 0.82-kb EcoRI-digested cDNA fragment in pUC vector; both probes were purchased from American Type Culture Collection (Rockville, MD). The human hepatocyte iNOS cDNA fragment of 2.1 kb was digested from pBluescript SK with EcoRI and BamHI (obtained from Dr. D. Geller, University of Pittsburgh, Pittsburgh, PA) (24) . Probing with the cDNA for cyclophilin n~NA was used as a control for the amount of total RNA loaded in each lane. mRNA was detected using a 0.7-kb BamHI cDNA fragment of rat cyclophilin gene, isolated from pCD vector (obtained from Dr. J. G. Sutcliffe, The Scripps Research Institute, La Jolla, CA). For cytokines and iNOS, the exposure was 6 to 9 d, while, for cyclophilin, exposure was overnight. For reprobing of the same membrane with another cDNA, the membrane was stripped of the hybridized probe with 0.1 • SSC/0,1% SDS at boiling temperature for 20 rain. The autoradiograms were quantitated using a laser densitometer (Ultroscan XL; LKB Instruments, Inc., Gaithersburg, MD) to estimate the levels of mRNA of genes that were transcribed. The ratio of cytokine mRNA induced by treated glial cells was compared with the mRNA levels of cyclophilin gene.
Statistical Analysis. The levels of IL-1, TNF-cq and NOxproduced by stimulation of gila were analyzed for significance by means of a multivariate analysis of variance (ANOVA). The paired Student's t test was performed comparing IL-1, TNF-cx, or NOx-activity in post facto analyses.
Results
Cellular Composition of Human Mixed Glial Cultures.
Markers for cell identification in fetal, neonatal, and adult cultures grown in two types of medium are shown in Table  1 . There are no significant numbers of oligodendrocytes, endothelial cells, or neurons in these cultures. HLA-DR molecules were seen predominantly on astrocytes and not microglia. CD4 molecules were not present on fetal glia. We believe the minor population of CD4-positive cells in neonatal and adult brain cultures may be blood-borne macrophages or pefivascular microglia (also blood-derived) contaminants and not parenchymal microglia. As enumerated by glial fibrillary acidic protein or e~-LDL, there were equal proportions of astrocytes and microglia, respectively, in fetal, neonatal, and adult mixed glial cultures whether they were cultured in CYTO or GCT. Microglia were also identified by EBM-11 and RCA-1. EBM-11 identified fewer microglia than did cI-LDL in fetal and neonatal cultures and disappeared entirely from microglia in adult cultures. RCA-1 identified all microglia and stained up to 50% of astrocytes in fetal and neonatal cultures, but not adult cultures (Table 1) .
Infection of and Pathology in Human Mixed
Glial Cell Culture Exposed to HIV-1. There are very few published studies on the infection of primary cultures of human glia, and the data are not always in agreement. Because of this, and because there is controversy as to the presence of CD4 on microglia in vivo and in vitro and whether it is the gp120 We compared GCT (a "black box" cocktail of cytokines)-grown cells to cells grown in a well-defined cytokine cocktail (CYTO, Table 1 ) that promotes survival and proliferation of microglia. For PCR analyses, infection with heat-inactivated virus was performed in parallel with live virus. This control provides a background level for viral DNA contaminating the virus stocks. This contaminant DNA presumably arises from lysis of virions from infected cells during preparation of the stock. Regardless of the excess amount of virus used to infect glial cells, there was relatively little infection compared with PBLs. HIV-1 strains NL4-3 andJR-CSF never produced detectable infection over background in any culture. The more macrophage-tropic HIV-1jR_FL and recombinant NFN-SX strains produced an extremely low level of infection in four out of five fetal brains, using either fresh tissue or cultured cells. Cultured fetal cells were infected only minimally when in the GCT medium ( Fig. 1 /3 ). In contrast, we detected virus only rarely in neonatal tissue (only twice in 10 different brain cultures) and only if cells were in medium containing IL-3, GM-CSF, and M-CSF (CYTO, Fig. 1 B) . Adult tissue, cultured either in CYTO or in GCT, was never detectably infected ( Fig. 1 A, Table  2 ). The positive infections in PBL controls, which were analyzed within the first 20 h of infection such that no virus spread could occur, produced HIV-1 copy numbers in the hundreds to thousands, indicating the highly infectious nature of the virus stocks (Fig. 1, Table 2 ). Fresh preparations of fetal glial cells were infected at the same level as cultured fetal glia, suggesting that the culture conditions were not an explanation for low levels of HIV-1 infection. Similar data were generated whether RJU5 or LTR/gag primer pairs were used. When infection occurred, cultures were positive for infection by PCR. analysis at 72 h. Culturing cells out to 12 d did not change these results (data not shown).
In spite of the low level of infection, a certain amount of morphological change occurred in fetal cultures exposed to virus. Fig. 2 demonstrates in vitro "pathology" in cultures that were not productively infected with the NFN-SX strain. GCT cultures displayed changes that were somewhat different from those in CYTO cultures, in that GCT cultures exposed to HIV-1 became gliotic. Astrocytes changed from an epitheloid to a spindly morphology (Fig.  2, days 2 and 12 ). Large clumps of both microglia and astroglia developed as determined by double staining (Fig. 2 , days 2 and 12 and data not shown). The morphology of the mixed glia was not as dramatically altered in CYTO cultures (e.g., not as much gliosis). Nevertheless, monolayers did not grow in a confluent manner (Fig. 2, day 12) , and microglia were increased in numbers in these cultures (Fig.  2, day 7) .
IL-1 and TNF-oe Induction in Human Mixed Glial Cultures.
Neither human microglia nor astrocytes produce as much IL-1 or TNF-o/ when cultured as isolated subsets as they do when cultured together, where they synergize to produce maximal cytokines (28, 29) . Because coculturing both cell types is more relevant to the inflammatory milieu in vivo, we did not separate them into subpopulations for induction of cytokines or N O . Figs. 3 and 4 demonstrate that HIV-1 env proteins and heat inactivated virus induce IL-1 and TNF-o~ proteins and mP, N A in human glial cell cultures, and that the age of tissue and culture conditions make a difference in the amount of cytokines induced. In contrast, in adult cultures, no differences in any vPE induction except vPE21 were seen in C Y T O medium, while, in G C T , vPE16, -17, -18, and -12 induced significantly more IL-1 than vPE8, -20, and -21 (Fig. 3) . vPE21 induced the lowest levels of IL-1 in all cultures. The M Qtropic strain was significantly better than the T cell-tropic strain at IL-1 induction in fetal, neonatal, and adult cells cultured in C Y T O . Recombinant gp41 induced a small but significant IL-1 response compared with the medium control.
Fetal and neonatal cells behaved differently from adult n a n t gp41 p r o t e i n a n d b y t h e p o w e r o f Figure 4 . Northern blot analysis oflL-1, TNF-ot, and iNOS mRNA induction in human fetal mixed glial cultures. Glial cells were incubated for 1 h or 3 h with stimuli for cytokine mR.NA and 6 h for iNOS ml<NA. Positive control were 5 ng/ml human IL-113 plus 70 ng/ml human IFN-y. Negative controls were medium alone or WP,-infected HeLa cell supernatants. Total 1<NA at 30 p.g/Iane was electrophoresed. Blots were exposed to film 6 d for IL-115 and iNOS mRNA, 9 d for TNF-c~ mR.NA, and overnight for cyclophilin mRNA. (A) Autoradiograms were quantified by densitometry, and the ratio of cytokine mRNA to cyclophilin m R N A was calculated. (B) As in A, the ratio of iNOS to cydophilin mRNA was calculated.
v P E 1 6 to i n d u c e IL-1 b e t t e r t h a n t r u n c a t i o n v P E s w i t h d eletions in gp41. R e m o v a l o f t h e V 3 l o o p (vPE21) significantly r e d u c e d IL-1 i n d u c t i o n . In fetal a n d n e o n a t a l c u ltures, t h e c o n f o r m a t i o n a l i n t e r a c t i o n o f g p 1 2 0 a n d gp41 m a y b e i m p o r t a n t , since v P E 1 2 (an u n c l e a v a b l e g p l 6 0 ) gave a significantly l o w e r IL-1 i n d u c t i o n t h a n did v P E 1 6 . Fig. 3 also d e m o n s t r a t e s t h e i n d u c t i o n o f T N F -( x in fetal, n e o n a t a l , a n d adult glial cultures. In c o n t r a s t to m e d i u m / c o f a c t o r -d e p e n d e n t d i f f e r e n c e s s e e n in IL-1 i n d u c t i o n ( w i t h a single e x c e p t i o n o f fetal in G C T i n d u c t i o n b y N F N -S X ) , T N F -( i i n d u c t i o n was t h e s a m e in G C T a n d C Y T O m e d i u m in fetal, n e o n a t a l , a n d adult cultures. In r e s p o n s e to v P E 1 8 , -8, a n d -2 1 , n e o n a t a l glial cells p r od u c e d significantly m o r e TNF-oL t h a n d i d adult o r fetal cells, w h i c h w e r e n o t significantly different f r o m e a c h other at any data point. As with IL-1, adult, neonatal, and fetal cultures specifcally produced the same amount of TNF-ot in response to heat-inactivated virus and recombinant gp41.
In fetal cultures, vPE16, -17, -18, and -12 induced the same levels of TNF-ot but significantly more than was induced by vPE8 and -20, which produced similar TNF-oc This suggests that gp41 is important and the V3 loop is not important in TNF-ot production. Likewise, in neonatal and adult cultures, removal of all gp41 epitopes (as in vPE8, -20, -21) significantly reduced TNF-0~ in contrast to what was seen for IL-1. vPE21 did not induce significant TNF-o~ in any cultures. In contrast to IL-1 induction, gp41 stimulated as much TNF-o~ as did vPE16 and heat-inactivated virus induction. These data suggest a more important role for gp41 in TNF-~x than IL-1 induction. In fetal cultures, the M O -t r o p i c strain induced significantly more TNF-o~ than did the T cell-tropic strain; there was no tropism in TNF-0r induction in neonatal or adult cultures.
To determine whether the induction oflL-1 and TNF-ci was being regulated at the mlKNA level, Northern blot analyses oflL-1 and TNF-oe mlKNA from fetal cultures before and after env protein stimulation were performed compared with the housekeeping cyclophilin gene. In Fig.  4 A, it can be seen that the negative controls, medium, or W1K vaccinia virus did not induce IL-1 or TNF-cx mlKNA. Likewise, vPE21, which did not induce protein, also did not induce mlKNA. The positive control I F N -y / I L -1 was a strong inducer of both cytokine mlKNAs in either medium (GCT or CYTO). For tL-1, vPE16 was a better inducer than vPE8 or vPE20, a difference that was greater in C Y T O than G C T in parallel with protein data (Fig. 3) . The differences among vPE16, -18, and -20 . Means "4-SD are shown for eight different fetal brains cultured and exposed to above stimuli. Except for gp160 in GCT, p24 (CYTO) vs gp160 (CYTO), gp120, gp41, and IFN-y/IL-1 (CYTO and GCT), P ~< 0.001. p24 (GCT) or MED vs all responses, P ~< 0.0001. Except for gp160, there were no significant differences between GCT and CYTO cultures stimulated with gp120, gp41, and IFN-~//IL-1. vPE16, -17, -8 vs WIK, vPE20, and vPE21, P ~< 0.0001. CYTO, gp160, gp120, gp41, and IFN-"//IL-1 vs from vPE16, -17, -8, P ~< 0.0(15. The nmltivariate ANOVA and paired Student's t test analyses were used for statistical significance.
Discussion
This is the first report to our knowledge showing that envelope proteins of HIV-1 are capable of inducing cytokines and N O in normal human glial cultures. W e and others have demonstrated N O production by rat microglia (13, 23, 25) and a role for TNF-0~ and N O in white matter damage, including toxicity for oligodendrocytes and inhibition of myelin gene expression (26, 27) . W e have suggested that N O may damage oligodendrocytes without killing them. This is particularly relevant to CNS AIDS, where oligodendrocytes are only destroyed very late in disease (1) but myelin damage is seen, especially in spinal cord, even in the presence of oligodendrocytes (28) . N O may also be of importance in neuronal toxicity and loss in CNS AIDS (1) . Although the literature is at variance over how neuronal toxicity is produced in vitro, most studies show indirect toxic events as opposed to direct infection (29 and references therein).
W e hypothesize that IL-1, TNF-ci, and N O production after env protein stimulation are interrelated and result in the gliotic pathology seen in vivo and as shown in vitro in this study. In vivo in AIDS brains, astrocytes undergo gliosis because of hypertrophy (30); in these circumstances, glial fibrillary acidic protein positivity by immunohistochemistry increases (1, 30) . IL-1, T N F -a , and N O cause a gliotic response in both microglia and astrocytes in vitro (14, 31) . Thus, we presume env proteins are indirectly in-ducing the microgliosis shown in vitro in this study. While NO may cause gliosis, we would predict little or no other perceptible toxic effect in these cultures. We and others have shown that NO inhibits mitochondrial function in astrocytes, but it does not kill them. NO has virtually no toxic effect on microglia (23, 27) .
If the production of NO in our cultures is the indirect result of IL-1 and TNF-cx production or a direct effect of gp120/gp41 on NFKB, it is not clear why there is a rather long interval between IL-1 and TNF-e~ production (peak 4-24 h) and peak NO production (3-7 d). Posttranslational regulation ofiNOS may be an important component in the delay in NO production. This is currently being examined. As we have suggested in these studies, HIV-1 need not infect glial cells to contribute to pathology in the CNS. While it is clear that HIV-1 infects CNS microglial cells in vivo, productively infected cells are rare in the brains of pediatric AIDS patients. The in vivo infections are latent or defective (1-3, 32, 33) . Even the culturing of microglia from infected pediatric brain tissue requires 30 d before viral replication is readily apparent, indicating the extremely slow virus life cycle or poor infectivity leading to slow spread of infection (34) . In vitro infection of astrocytes from fetal brain results in a transient, partially defective viral replication (7) (8) (9) . In vivo, astrocytes are not productively infected (1) but nef protein is expressed in a small proportion of astrocytes in pediatric AIDS brain tissues (35) . A restricted or latent infection in glia is therefore thought to lead to indirect but extensive neuropathogenesis.
While several reports claim microglia in brain tissue and in tissue culture have CD4 on their surface (10, 34) , which contributes to HIV-1 infection (10), many other studies have failed to detect CD4 on parenchymal microglia in fetal or adult brain from normal or HIV-l-positive brain tissue (11, 12, 36, 37), nor has CD4 been seen to be inducible on microglia in vitro (37) . It is thought that the CD4 + cells in brain are blood-derived perivascular CNS macrophages (11, 36). Since we document a significant number of microglia in our cultures (which are CD4-), either the Watkins study (10) and follow-up studies from the same laboratory were demonstrating infection of blood-borne, perivascular brain macrophages and not microglia, or other culture conditions in the Watkins study allowed for CD4 expression and/or infection. The infection we achieved in fetal cultures, while significantly above controls and on a fairly consistent basis, was extremely low compared with PBL controls. The fetal tissue we used was taken during the second trimester and was therefore older than that in one study (11) but similar to that in another (12) . Nevertheless, the level of infection in our study was significantly lower than that reported by Lee et al. (12) . Additionally, the inability to infect human glia in vitro and the differences seen in TNF-o~, IL-1, and NO production when cells are in different medium conditions suggest that the in vitro cofactors are not identical to in vivo cofactors, or that in vivo infection of glia is indirectly achieved by fusion of infected blood monocytes with brain cells.
In summary, this study reconfirms two previous studies on rat glial cells demonstrating a functional cytokine response to non-CD4 epitopes in gp120 and to the amino terminus ofgp41 (18, 19) . IL-1, TNF-cx, and iNOS can be induced at the mRNA level by env proteins and HIV-1 virus in the absence of infection. Their production is induced and regulated differently, given that media with different cofactors and different env domains give different IL-1 or TNF-c* responses. The responses in adult, neonatal, and fetal glial cultures are also different, even though the cellular composition of the cultures appears to be identical. The V3 loop and carboxy terminus of gp120 and to a lesser extent gp41 are important for IL-1. The V3 loop of gp120 is less important and gp41 is more important in TNF-ot than in IL-1 induction. While the macrophage-tropic strain of HIV-1 tends to be a better inducer of cytokines, a significant IL-1 and TNF-0~ response occurs with a T cell-tropic strain of HIV-1. Further mapping of distinct sequences within gp120 and gp41 that are responsible for TNF and IL-1 production and the role of these cytokines in NO induction is part of the ongoing research in this lab. Elucidation of these interactions will provide a basis for designing therapeutic interventions to use in treating CNS AIDS.
